|
1
|
Takes RP, Rinaldo A, Silver CE, Haigentz M
Jr, Woolgar JA, Triantafyllou A, Mondin V, Paccagnella D, Bree R,
Shaha AR, et al: Distant metastases from head and neck squamous
cell carcinoma. Part I. Basic aspects. Oral Oncol. 48:775–779.
2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Senft A, Yildirim G, Hoekstra OS,
Castelijns JA, Leemans CR and de Bree R: The adverse impact of
surveillance intervals on the sensitivity of FDG-PET/CT for the
detection of distant metastases in head and neck cancer patients.
Eur Arch Otorhinolaryngol. 274:1113–1120. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peters TT, Senft A, Hoekstra OS,
Castelijns JA, Witte BI, Leemans CR and de Bree R: Pretreatment
screening on distant metastases and head and neck cancer patients:
Validation of risk factors and influence on survival. Oral Oncol.
51:267–271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Deurvorst SE, Hoekstra OS, Castelijns JA,
Witte BI, Leemans CR and de Bree R: Clinical value of
18FDG PET/CT in screening for distant metastases in head
and neck squamous cell carcinoma. Clin Otolaryngol. 43:875–881.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Haigentz M Jr, Hartl DM, Silver CE,
Langendijk JA, Strojan P, Paleri V, de Bree R, Machiels JP, Hamoir
M, Rinaldo A, et al: Distant metastases from head and neck squamous
cell carcinoma. Part III. Treatment. Oral Oncol. 48:787–793.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wiegand S, Zimmermann A, Wilhelm T and
Werner JA: Survival after distant metastasis in head and neck
cancer. Anticancer Res. 35:5499–5502. 2015.PubMed/NCBI
|
|
7
|
Pietropaoli MP, Damron TA and Vermont AI:
Bone metastases from squamous cell carcinoma of the head and neck.
J Surg Oncol. 75:136–141. 2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Suzuki A, Kashiwagi N, Doi H, Ishii K, Doi
K, Kitano M, Kozuka T, Hyodo T, Tsurusaki M, Yagyu Y and Nakanishi
K: Patterns of bone metastases from head and neck squamous cell
carcinoma. Auris Nasus Larynx. 47:262–267. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al-Bulushi NK and Abouzied ME: Comparison
of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting
bone metastasis in head and neck tumors. Nucl Med Commun.
37:583–588. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lee DH, Kim MJ, Roh JL, Kim SB, Choi SH,
Nam SY and Kim SY: Distant metastases and survival prediction in
head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg.
147:870–875. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bollig CA, Newberry CI, Galloway TL,
Zitsch RP, Hanly EK, Zhu VL, Pagedar N, Nallani R, Bur AM, Spanos
WC and Jorgensen JB: Prognostic impact of metastatic site and
pattern in patients with metastatic head and neck cancer.
Laryngoscope. 131:E1838–E1846. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Argiris A, Li Y and Forastiere A:
Prognostic factors and long-term survivorship in patients with
recurrent or metastatic carcinoma of the head and neck. Cancer.
101:2222–2229. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Recondo G, Armand JP, Tellez-Bernal E,
Domenge C, Belehradek M, Vathaire FD, Wibault P, Richard JM and
Cvitkovic E: Recurrent and/or metastatic head and neck squamous
cell carcinoma: A clinical, univariate and multivariate analysis of
response and survival with cisplatin-based chemotherapy.
Laryngoscope. 101:494–501. 1991.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Grünwald V, Chirovsky D, Cheung WY,
Bertolini F, Ahn MJ, Yang MH, Castro G, Berrocal A, Sjoquist K,
Kuyas H, et al: Global treatment patterns and outcomes among
patients with recurrent and/or metastatic head and neck squamous
cell carcinoma: Results of the GLANCE H&N study. Oral Oncol.
102(104526)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Duprez F, Berwouts D, De Neve W, Bonte K,
Boterberg T, Deron P, Huvenne W, Rottey S and Mareel M: Distant
metastases in head and neck cancer. Head Neck. 39:1733–1743.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cho H, Nishiike S, Yamamoto Y, Takenaka Y,
Nakahara S, Yasui T, Hanamoto A and Inohara H: Docetaxel,
cisplatin, and fluorouracil for patients with inoperable recurrent
or metastatic head and neck squamous cell carcinoma. Auris Nasus
Larynx. 42:396–400. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mirabile A, Miceli R, Calderone RG, Locati
L, Bossi P, Bergamini C, Granata R, Perrone F, Mariani L and
Licitra L: Prognostic factors in recurrent or metastatic squamous
cell carcinoma of the head and neck. Head Neck. 41:1895–1902.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Argiris A, Li S, Ghebremichael M, Egloff
AM, Wang L, Forastiere AA, Burtness B and Mehra R: Prognostic
significance of human papillomavirus in recurrent or metastatic
head and neck cancer: An analysis of Eastern Cooperative Oncology
Group trials. Ann Oncol. 25:1410–1416. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vermorken JB, Psyrri A, Mesía R, Peyrade
F, Beier F, de Blas B, Celik I and Licitra L: Impact of tumor HPV
status on outcome in patients with recurrent and/or metastatic
squamous cell carcinoma of the head and neck receiving chemotherapy
with or without cetuximab: Retrospective analysis of the phase III
EXTREME trial. Ann Oncol. 25:801–807. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Deeken JF, Newkirk K, Harter KW, Marshall
MB, Banovac F, Johnson L, Wang H, Wang Y, Zhuang T, Ja AK, et al:
Effect of multimodality treatment on overall survival for patients
with metastatic or recurrent HPV-positive head and neck squamous
cell carcinoma. Head Neck. 37:630–635. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ahn MJ, Chirovsky D, Kuyas H, Auclair V,
Abounit S, Joo S, Shah R and Yang MH: Global longitudinal
assessment of treatment outcomes in recurrent/metastatic
nasopharyngeal carcinoma: GLANCE-NPC study. Future Oncol.
17:2015–2025. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang H, Zhu W, Biskup E, Yang W, Yang Z,
Wang Z, Qiu X, Zhang C and Hu G and Hu G: Incidence, risk factors
and prognostic characteristics of bone metastases and
skeletal-related events (SREs) in breast cancer patients: A
systematic review of the real world data. J Bone Oncol. 11:38–50.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Koizumi M, Yoshimoto M, Kasumi F and Ogata
E: Comparison between solitary and multiple skeletal metastatic
lesions of breast cancer patients. Ann Oncol. 14:1234–1240.
2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bae HM, Lee SH, Kim TM, Kim DW, Yang SC,
Wu HG, Kim YW and Heo DS: Prognostic factors for non-small cell
lung cancer with bone metastasis at the time of diagnosis. Lung
Cancer. 77:572–577. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang L and Gong Z: Clinical
characteristics and prognostic factors in bone metastases from lung
cancer. Med Sci Monit. 23:4087–4094. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Portales F, Thézenas S, Samalin E, Assenat
E, Mazard T and Ychou M: Bone metastases in gastrointestinal
cancer. Clin Exp Metastasis. 32:7–14. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yamamoto Y, Okuda Y, Kanaki T, Tanaka R,
Nagahara A, Nakai Y, Nakayama M, Kakimoto K and Nishimura K:
Clinical indicators for predicting prognosis after radium-223
administration in castration-resistant prostate cancer with bone
metastases. J Clin Oncol. 26:192–198. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Imura Y, Tateiwa D, Sugimoto N, Inoue A,
Wakamatsu T, Outani H, Tanaka T, Tamiya H, Yagi T, Naka N, et al:
Prognostic factors and skeletal-related events in patients with
bone metastasis from gastric cancer. Mol Clin Oncol.
13(31)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Imura Y, Yamamoto S, Wakamatsu T, Tanaka
T, Tamiya H, Sugimura K, Miyata H, Ishihara R, Yano M and Naka N:
Clinical features and prognostic factors in patients with
esophageal cancer with bone metastasis. Oncol Lett. 19:717–724.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Outani H, Akita H, Nakai T, Takada R,
Imura Y, Tanaka T, Tamiya H, Oshima K, Takahashi H, Ohkawa K, et
al: Clinical features and prognosis of patients with the bone
metastasis of pancreatic cancer: A single-institutional cohort
study. Pancreas. 47:e43–e46. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nørgaard M, Jensen AØ, Jacobsen JB, Cetin
K, Fryzek JP and Sørensen HT: Skeletal related events, bone
metastasis and survival of prostate cancer: A population based
cohort study in Denmark (1999 to 2007). J Urol. 184:162–167.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li X, Hu W, Sun H and Gou H: Survival
outcome and prognostic factors for colorectal cancer with
synchronous bone metastasis: A population-based study. Clin Exp
Metastasis. 38:89–95. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Santini D, Tampellini M, Vincenzi B,
Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C,
Calipari N, et al: Natural history of bone metastasis in colorectal
cancer: Final results of a large Italian bone metastases study. Ann
Oncol. 23:2072–2077. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Coleman RE: Skeletal complications of
malignancy. Cancer. 80 (Suppl 8):S1588–S1594. 1997.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Huang F, Wu G and Yang K: Oligometastasis
and oligo-recurrence: More than a mirage. Radiat Oncol.
9(230)2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Weichselbaum RR and Hellman S:
Oligometastases revisited. Nat Rev Clin Oncol. 8:378–382.
2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Thomas TV, Packianathan S, Bhanat E,
Albert A, Abraham A, Gordy X, Kanakamedala M, Mehta D and
Vijayakumar S: Oligometastatic head and neck cancer: Comprehensive
review. Head Neck. 42:2194–2201. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Albergotti WG, Abberbock S, Mathews F,
Ferris RL, Johnson JT, Duvvuri U and Kim S: Oligometastatic status
as predictor of survival in metastatic human
papillomavirus-positive oropharyngeal carcinoma. Head Neck.
40:1685–1690. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Webb BJ, Dascomb K, Stenehjem E and Dean
N: Predicting risk of drug-resistant organisms in pneumonia: Moving
beyond the HCAP model. Respir Med. 109:1–10. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
La EM, Smyth EN, Talbird SE, Li L, Kaye
JA, Lin AB and Bowman L: Treatment patterns and health care
resource use in patients receiving multiple lines of therapy for
metastatic squamous cell carcinoma of the head and neck in the
United Kingdom. Eur J Cancer Care (Engl). 27(e12862)2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Cramer JD, Hicks KE, Rademaker AW, Patel
UA and Samant S: Validation of the eighth edition American Joint
Committee on cancer staging system for human
papillomavirus-associated oropharyngeal cancer. Head Neck.
40:457–466. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Head and Neck Cancer Study Group (HNCSG).
Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N,
Kodaira T, Zenda S, Fujii H, et al: A review of head and neck
cancer staging system in the TNM classification of malignant tumors
(eighth edition). Jpn J Clin Oncol. 49:589–595. 2019.PubMed/NCBI View Article : Google Scholar
|
